ASR Vermogensbeheer’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$47M Sell
93,709
-9,824
-9% -$4.72M 0.48% 39
2026
Q1
$50.9M Buy
103,533
+871
+0.8% +$473K 0.6% 26
2025
Q4
$59.5M Sell
102,662
-7,529
-7% -$4.26M 0.69% 23
2025
Q3
$53.4M Sell
110,191
-6,601
-6% -$3.07M 0.65% 26
2025
Q2
$47.4M Buy
116,792
+12,541
+12% +$5.24M 0.61% 30
2025
Q1
$51.9M Buy
+104,251
New +$56.5M 0.77% 24

Other funds holding TMO

ASR Vermogensbeheer's TMO Position: Q2 2026 in Review

ASR Vermogensbeheer reduced its Thermo Fisher Scientific (TMO) stake by 9.5% in Q2 2026, selling an estimated $4.72M and leaving 93,709 shares worth $47M. The position accounts for 0.48% of the portfolio, ranked #39.

ASR Vermogensbeheer first reported a position in TMO in Q1 2025 and has held it in 6 quarters since. The position peaked at $59.5M in Q4 2025. 2,603 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • ASR Vermogensbeheer held 93,709 shares of Thermo Fisher Scientific worth $47M as of Q2 2026.
  • ASR Vermogensbeheer sold 9,824 Thermo Fisher Scientific shares in Q2 2026, an estimated $4.72M.
  • Thermo Fisher Scientific made up 0.48% of ASR Vermogensbeheer's portfolio in Q2 2026, its #39 holding.
  • ASR Vermogensbeheer first reported a position in Thermo Fisher Scientific in Q1 2025 and has held it in 6 quarters since.
  • ASR Vermogensbeheer's Thermo Fisher Scientific position peaked at $59.5M in Q4 2025.
  • 2,603 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on ASR Vermogensbeheer's 13F filing for Q2 2026, filed 20 Jul 2026.